Compare · WBA vs YI
WBA vs YI
Side-by-side comparison of Walgreens Boots Alliance Inc. (WBA) and 111 Inc. (YI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both WBA and YI operate in Retail-Drug Stores and Proprietary Stores (Consumer Staples), so they compete in similar markets.
- WBA is the larger of the two at $43.56B, about 93.4x YI ($466.6M).
- Over the past year, WBA is up 9.5% and YI is down 19.9% - WBA leads by 29.4 points.
- YI has hit the wire 2 times in the past 4 weeks while WBA has been quiet.
- WBA has more recent analyst coverage (19 ratings vs 0 for YI).
- Company
- Walgreens Boots Alliance Inc.
- 111 Inc.
- Price
- $12.01+0.67%
- $6.67+0.00%
- Market cap
- $43.56B
- $466.6M
- 1M return
- +3.18%
- +7.58%
- 1Y return
- +9.49%
- -19.88%
- Industry
- Retail-Drug Stores and Proprietary Stores
- Retail-Drug Stores and Proprietary Stores
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2018
- News (4w)
- 0
- 2
- Recent ratings
- 19
- 0
Walgreens Boots Alliance Inc.
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides specialty pharmacy services and mail services. As of August 31, 2020, this segment operated 9,021 retail stores under the Walgreens and Duane Reade brands in the United States; and six specialty pharmacies. The Retail Pharmacy International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty stores and optical practices, as well as through boots.com and an integrated mobile application. This segment operated 4,428 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 550 optical practices, including 165 on a franchise basis. The Pharmaceutical Wholesale segment engages in the wholesale and distribution of specialty and generic pharmaceuticals, health and beauty products, and home healthcare supplies and equipment, as well as provides related services to pharmacies and other healthcare providers. This segment operates in the United Kingdom, Germany, France, Turkey, Spain, the Netherlands, Egypt, Norway, Romania, the Czech Republic, and Lithuania. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
111 Inc.
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Drug Mall, including pharmacies and wholesalers; and digital contract sales organization and data services. As of December 31, 2020, it operated 13 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Wuhan, Tianjin, and Kunshan. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. 111, Inc. has strategic partnerships with Bayer Healthcare Co. Ltd.; BeiGene, Ltd.; and Jianming Pharmaceutical Group. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
Latest WBA
- SEC Form 15-12G filed by Walgreens Boots Alliance Inc.
- SEC Form SCHEDULE 13G filed by Walgreens Boots Alliance Inc.
- SEC Form S-8 POS filed by Walgreens Boots Alliance Inc.
- SEC Form S-8 POS filed by Walgreens Boots Alliance Inc.
- SEC Form S-8 POS filed by Walgreens Boots Alliance Inc.
- SEC Form S-8 POS filed by Walgreens Boots Alliance Inc.
- SEC Form POSASR filed by Walgreens Boots Alliance Inc.
- SVP Chief Corp Affairs Officer Fabbri Beth Amber L. returned 124,670 shares to the company, closing all direct ownership in the company (SEC Form 4)
- EVP and Global CFO Mahajan Manmohan returned 414,273 shares to the company, closing all direct ownership in the company (SEC Form 4)
- EVP, Global CLO & Corp. Sec. Minnix Lanesha returned 348,093 shares to the company, closing all direct ownership in the company (SEC Form 4)
Latest YI
- SEC Form 6-K filed by 111 Inc.
- 111, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results
- SEC Form 3 filed by new insider Teo Nee Chuan
- SEC Form 3 filed by new insider Luo Jun Justin
- SEC Form 3 filed by new insider Sun Jian David
- SEC Form 3 filed by new insider Chen Yang Luke
- SEC Form 3 filed by 111 Inc.
- SEC Form 3 filed by 111 Inc.
- SEC Form 6-K filed by 111 Inc.
- 111, Inc. Announces Third Quarter 2025 Unaudited Financial Results